We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Patent Granted for Shorter SPECT Scan Times

By HospiMedica staff writers
Posted on 09 Jun 2006
The U.S. More...
Patent and Trademark office has granted a patent to a manufacturer of single photon emission tomography (SPECT) systems for shorter scanning time and clinically diagnostic images.

These shorter scan times may be obtained by resolution recovery reconstruction methods such as the UltraSPECT patented Wide Beam Reconstruction (WBR) technology. This formal recognition allows UltraSPECT, Ltd. (Haifa, Israel) to continue to provide advanced and innovative nuclear medicine (NM) systems.

Scanning times of NM cardiac perfusion and bone SPECT studies range between 15 and 30 minutes in a traditional dual head gamma camera. Decreasing the scan time of NM procedures while maintaining image quality is a desirable characteristic for very busy NM clinics as well as for patient comfort. Xpress.cardiac and Xpress.bone, two of the systems that are marketed by UltraSPECT, demonstrate that scan times can be reduced by a factor of two or more with no degradation of image quality.

"Reducing the scan time of a typical high-quality stress cardiac study to five minutes, using the WBR technology, compares to the revolution that the dual detector cameras made more than a decade ago,” said Dr. Israel Ohana, co-inventor of the patent. "UltraSPECT is developing the next generation of products based on this patent, with further reduction of scan time to less than three minutes.”

UltraSPECT develops resolution recovery systems that enhance productivity and image quality of nuclear medicine and nuclear cardiology departments. Its products, targeting the various NM applications, are based on its innovative and patented WBR technology, which enables a gamma camera to provide excellent productivity and image quality.

Optimized for each application, the WBR protocols are fully automatic, require no user intervention, and are optimized for all patients regardless of age and size.



Related Links:
UltraSPECT

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.